Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panelHartmut Döhner, Clara D. Bloomfield, Elihu H. Estey et al.|Blood|2016Cited by 5.9k
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetHartmut Döhner, Clara D. Bloomfield, Elihu H. Estey et al.|Blood|2009Cited by 3.4k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELNHartmut Döhner, Bob Löwenberg, Andrew H. Wei et al.|Blood|2022Cited by 3k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> MutationRichard M. Stone, Hartmut Döhner, Sumithra J. Mandrekar et al.|New England Journal of Medicine|2017Cited by 2.2k
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group studyMarilyn L. Slovak, Frederick R. Appelbaum, Kenneth J. Kopecky et al.|Blood|2000Cited by 1.6k